About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
GLP-1s have exploded in popularity, to the where, a ccording to the Kaiser Family Foundation, 12% of adults has taken Ozempic ...
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...
"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. She said these cost-of-care conversations are now a daily occurrence. While glucagon-like ...
Nestlé has created a new frozen food line, aimed at people taking GLP-1 medications. Experts say maintaining a healthy diet ...
GLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing. CMS has taken steps ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs for weight loss.
Drug Stocks latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...